Magazine - 12 Nov 2020 | Shares Magazine

Menu

Archives
Magazine - 12 Nov 2020

Shares Magazine Cover Image

Download Read now

Find out the best and worst performing sectors during the vaccine-inspired global market rally.

Shares analyses the market movements to spot shifts in investor behaviour and the stocks which are still some way behind their pre-Covid levels.

Find out what's next for Pfizer and when other important vaccine drug trial news is scheduled. Discover how investors are repositioning portfolios after Joe Biden's election win.

News

Is the vaccine news a game-changer or just a good start?

The next steps for Pfizer and other drug trial news to watch

News

Where we stand after markets’ vaccine boost

Taking a look at the sectors which shone and those which struggled

Great Ideas

Novacyt shares buffeted by positive vaccine news

Given the wide dispersion of possible outcomes for the company’s earnings, the shares were always going to be a bumpy ride

Great Ideas

Make your play for discounted payments star PayPal

The business lies at the heart of several mega-trends set to power the share price

News

McDonald’s beats expectations but Beyond Meat bombs

Hot on the heels of food companies reporting, next week brings numbers from big US retailers

Great Ideas

Time for a comeback? This Asian fund has attractive qualities

Aberdeen Standard Asia Focus enables investors to access high-quality Asian small caps at a big discount

News

Investors reposition portfolios after Biden win

The election victory has made it easier to spot the likely winning trades

Great Ideas

Premier Foods is bringing in the dough

The food producer has positive earnings momentum ahead of the important Christmas selling season

Russ Mould

Why Turkey could still trouble global markets

The latest turmoil in the country may be flying under the radar but it could create real problems

Great Ideas

We expect further good news from Smurfit Kappa

The stock is up 6% since we said to buy a month ago following a strong third quarter update

Editor's View

Investors right to be more enthusiastic about the future

The big reaction to vaccine news is justified - up to a point

News

Latest takeovers focus on two specific groups of stocks

Activity is spread across diverse sectors from insurance to biotech to gaming, suggesting a healthy appetite for UK companies

Under The Bonnet

Starbucks is ready to roast the competition

The coffee company is both a growth and income stock and looks a post-Covid world winner

Feature

Why acquisitions can be good, bad and ugly

They are an effective way to grow quickly, but there are risks to understand

Feature

FTSE income favourites: time for a rethink?

It’s not worth owning a stock for income if it is losing you money

Ask Tom

Should I set up a SIPP if I have a workplace pension?

The reasons for saving for retirement on top of a salary sacrifice scheme

Personal Finance

Managing your finances in lockdown 2.0

Why getting on top of any debt, having emergency tax savings and tax wrappers are all important

Funds

Know your fund: Unusual lockdown winners boost Rathbone Global

The fund has raced ahead of its benchmark thanks tech firms and vaccine makers, but also dating and pet stocks

Case study

Investor diary: Expanding horizons

We continue our series looking at how Malcolm is running his own pension

Funds

AJ Bell targets best of ESG investing world with new fund

The focus is on companies with high socially responsible investment scores